Table 2 Prevalence and logistic regression of sedative-hypnotic use

 65–74

2.4

1.00

–

2.6

1.00

–

 75–84

4.1

1.52***

1.41–1.65

3.9

1.31***

1.21–1.42

  ≥ 85

6.2

2.56***

2.28–2.87

4.0

1.43***

1.25–1.63

 Male

3.8

1.00

–

3.3

1.00

–

 Female

2.7

0.71***

0.65–0.76

3.0

0.96

0.89–1.04

 Fixed premium

4.0

1.49

0.93–2.37

3.8

2.30**

1.32–4.01

 Dependent

3.3

1.54

0.97–2.45

3.2

2.09**

1.20–3.65

  < 640 (< 20,000 NTD)

2.8

1.20

0.75–1.91

2.8

1.90*

1.09–3.32

 640–1280 (20,000–39,999 NTD)

2.8

1.42

0.82–2.45

2.4

1.71

0.91–3.23

  ≥ 1281(≥40,000 NTD)

2.0

1.00

–

1.4

1.00

–

 0

0.5

1.00

–

0.5

1.00

–

 1

2.6

5.47***

4.59–6.51

2.7

5.43***

4.57–6.46

 2

6.2

12.82***

10.72–15.34

5.7

11.63***

9.73–13.90

 3

10.4

23.08***

19.32–27.58

9.8

21.33***

17.89–25.45

 Northern

3.2

0.59***

0.50–0.71

3.1

0.76**

0.63–0.93

 Central

3.2

0.59***

0.49–0.71

3.7

0.93

0.76–1.14

 Southern

3.2

0.59***

0.50–0.71

2.8

0.69***

0.57–0.84

 Eastern

5.3

1.00

–

4.0

1.00

–

 Urban

3.2

0.82***

0.75–0.90

3.2

1.03

0.94–1.14

 Suburban

3.3

0.97

0.87–1.08

3.4

1.12*

1.00–1.25

 Rural

3.3

1.00

–

2.9

1.00

–

Total

3.2

3.1